BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
8.78
-0.19 (-2.12%)
At close: Apr 24, 2026, 4:00 PM EDT
8.95
+0.17 (1.94%)
After-hours: Apr 24, 2026, 5:29 PM EDT
BBOT Market Cap
BBOT has a market cap or net worth of $702.69 million as of April 24, 2026. Its market cap has increased by 177.53% in one year.
Market Cap
702.69M
Enterprise Value
279.99M
1-Year Change
177.53%
Ranking
Category
Stock Price
$8.78
Market Cap Chart
Since February 9, 2024, BBOT's market cap has increased from $38.21M to $702.69M, an increase of 1,738.90%. That is a compound annual growth rate of 274.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 702.69M | -29.83% |
| Dec 31, 2025 | 1.00B | 305.70% |
| Dec 31, 2024 | 246.84M | 545.98% |
| Feb 9, 2024 | 38.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Solid Biosciences | 779.29M |
| Design Therapeutics | 772.75M |
| Relmada Therapeutics | 756.24M |
| Vor Biopharma | 748.30M |
| Tenax Therapeutics | 719.30M |
| Alpha Tau Medical | 712.00M |
| Lexicon Pharmaceuticals | 711.78M |
| Gyre Therapeutics | 679.38M |